A new technology marks a turning point in the treatment of early-stage breast cancer ...
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent ...
The minimally invasive MINT® procedure offers a novel, sutureless solution for managing intraocular pressure in glaucoma patients....
Clinicians across the United Kingdom can now access Eko's advanced digital stethoscopes, auscultation accessories, and AI-supported tools via EkoHealth.com and Amazon UK....
New TS1200 model supports up to 300 lbs, offering hospitals a more efficient, scalable solution for surgical instrument transport and storage....
Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases. Molecular Fingerprinting: AI-Powered ‘DNA Barcode’ Spots 200+ Species, Including Uncultivable Pathogens. Hospital Laboratories Across Europe Now Have Immediate Access To a Fully Certified, Untargeted Molecular Diagnostics Platform. ...
Robotic-Assisted Platform Enhances Intraoperative Radiation Therapy for Neuro-Oncology and Breast Cancer Treatments...
The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology, AmorphOX®....
Collaboration Enhances Cancer Diagnostics by Integrating Advanced AI into Unified Imaging Workflows...
• Osteopore secures European Union Medical Device Regulation (EU MDR) approval to supply its cutting-edge custom orthopaedic and cranial implants. • EU MDR approval unlocks opportunities to offer high-value, custom implants to Europe, in addition to off-the-shelf implants, introducing new revenue streams. • Regulatory clearance validates Osteopore’s orthopaedic and cranial products in Europe, strengthening the Company’s positioning in the market. • The European orthopaedic market is projected...
